NUTX

Nutex Health Inc
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$1.38B
P/E Ratio
7.96
EPS
$25.24
Beta
2.00
52W High
$226.16
52W Low
$83.99
50-Day MA
$198.24
200-Day MA
$148.81
Dividend Yield
—
Profit Margin
21.20%
Forward P/E
—
PEG Ratio
—

About Nutex Health Inc

Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$846.72M
Gross Profit (TTM)$461.53M
EBITDA$502.27M
Operating Margin57.80%
Return on Equity64.60%
Return on Assets33.30%
Revenue/Share (TTM)$123.99
Book Value$57.62
Price-to-Book3.50
Price-to-Sales (TTM)1.62
EV/Revenue1.182
EV/EBITDA3.56
Quarterly Earnings Growth (YoY)95.90%
Quarterly Revenue Growth (YoY)-13.60%
Shares Outstanding$6.85M
Float$4.14M
% Insiders29.23%
% Institutions43.99%

Historical Volatility

HV 10-Day
52.46%
HV 20-Day
54.56%
HV 30-Day
53.79%
HV 60-Day
74.78%
HV Rank
8.7%

Volatility is currently contracting

Analyst Ratings

Consensus ($288.20 target)
1
Strong Buy
4
Buy

Latest News

Top Healthcare Stocks: Playing Offense And Defense For The Win

Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.

Seeking Alpha10/12/2026Positive
Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)

Nutex Health is rated Strong Buy, with a new target price of $290.43, representing 39.1% upside from current levels. NUTX's profitability and growth metrics significantly outpace peers, driven by effective use of the No Surprises Act and disciplined cost controls. Consensus EPS projections for FY2026 and FY2027 have materially increased, with FY2026 EPS now expected at $27.79, supporting a forward PE of just 10.5.

Seeking Alpha9/24/2026Positive
Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026

HOUSTON, Aug. 31, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced the awards and honors earned by its hospitals during the second quarter of 2026. Nutex Health hospitals have long served as trusted health care providers in their communities.

PRNewsWire8/31/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NUTX and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026